VIENNA, Jan. 30, 2025 /PRNewswire/ -- President & CEO Narek Sirakanyan gave a boost to the development of the group, introducing the new product qTest, opening new offices in Dubai and Bien Hoa (Vietnam) and promoting a more aggressive marketing strategy.
Narek Sirakanyan comments: 'The year 2024 marked our tenth anniversary. Now we are ready for a quantum leap targeting an IPO in 2029. I personally believe we must continue looking for projects characterized by innovation, scalability and social relevance. Our footprint now includes 19 countries and this year we'll open two more. We are ready to launch Firstline, our new app for the Horeca sector which complements our High-Tech area."
2024 Facts & Figures
The leading business on the group is Project V, focused on nutraceuticals for health, wellness and beauty. "Project V totaled a record revenue level of 130 million USD" said Sirakanyan, "and by the end of 2025 we target to reach 150 million USD in revenues. The Project V business was enriched in fall by the introduction of GH, a drinking complex in ampoules based on 6-year-old white imperial Ginseng. Now Project V offers 80 products and by the end of 2025 this number will grow to 100."
The Coffeecell business grew by 15% to 8,5 million USD and the plans for 2025 are to top the 10 million USD threshold. Two new products based on imperial Ginseng were introduced in 2024, G Black and G Legend.
On May 10, President & CEO Narek Sirakanyan presented the qTest, a world premiere, together with professor Torello Lotti, a renowned academician, who developed it. This system responds to an oxidation-reduction chemical reaction, or redox (short for reduction-oxidation), which is crossed with the level of saliva pH to determine the unique position of everyone taking the test.
QTest is now being exported to all main FIG markets.
Outlook for 2025
The goal is to position Project V in the fashion world as a "secret" source of health and energy for models' backstage at fashion shows. A first step in this direction will be the partnership with the Monte-Carlo Fashion Week, the official fashion event of the Principality of Monaco.
Concerning the High-Tech line, Freedom plans to introduce the Firstline app in the first quarter of 2025. "Firstline is a digital space where each business competes for existing and potential clients." Says Sirakanyan: "Firstline directly attracts its clients, returning money to them for the purchases and recommendations. Nothing to pay upfront to marketing agencies and other intermediaries. We plan to invest 3 million USD in marketing this year to launch the app and to reach a turnover of 15 million USD by the end of 2025."
This year the group plans to open two more office, in Riyadh (Saudi Arabia) and Milan (Italy).
www.freedomgroupint.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
The Freedom International Group, an investment company focusing on technology, finance, health & wellness, saw its client base grow to 2.2 million in 2024, marking an 8% increase compared to 2024.
BANGKOK, Feb. 20, 2025 /PRNewswire/ -- King Chulalongkorn Memorial Hospital and Thai Red Cross Society have launched the "Check PD" application for Parkinson's risk screening after statistics show that the disease rate among Thai people has increased and is found in individuals under 60 years old. The application boasts an accuracy rate of screening at 90%. Thai people, especially those 40 years and above, are encouraged to download the application to seek preventive methods or timely treatment.
Assoc. Prof. Dr. Chanchai Sittipunt, Dean of the Faculty of Medicine, Chulalongkorn University, and Director of King Chulalongkorn Memorial Hospital, said that the Check PD application is an innovation that uses digital technology, big data analytics, and artificial intelligence to help diagnose Parkinson's disease symptoms. Early detection is crucial for proper treatment planning and care, in line with King Chulalongkorn Memorial Hospital's strategy to create healthcare innovations, develop modern, accessible services, and improve the people's quality of life. The app represents successful collaboration between sectors, demonstrating commitment to implementing new technologies and innovations in healthcare. It helps those at risk of Parkinson's plan appropriate healthcare, prevention, and treatment.
Prof. Dr. Roongroj Bhidayasiri, Director of the Center of Excellence for Parkinson's Disease & Related Disorders (ChulaPD), Faculty of Medicine, Chulalongkorn University, revealed that Parkinson's disease doesn't show immediate symptoms but develops gradually over 10-20 years on average. The most recognizable sign is tremors. However, early warning signs like chronic constipation, sleepwalking, and acting out dreams during sleep, etc., are often seen as normal, leading to delayed medical attention. While the elderly are the primary risk group, those over 40 are also at risk. Statistics show that Parkinson's is inclined to affect increasingly younger patients, and, given the disease's long progression period, early risk screening is essential for prevention and treatment to minimize severe symptoms, suggested Prof. Dr. Roongroj.
Chula PD and the Thai Red Cross Society have developed the CHECK PD application, using digital technology, big data analytics, and AI to diagnose Parkinson's symptoms. The application aims to help those at risk appropriately plan their healthcare, prevention, and treatment in order to achieve good and sustainable quality of life. The application allows for self-screening of Parkinson's risk for those over 40 years old, using a 25-minute evaluation consisting of 20 questions. The evaluation includes questions as well as tests on finger movements, tremors, balance, and voice. It then responds with immediate results with 90% accuracy.
The application is available on the App Store and Play Store.
Watch the launch video of CheckPD at https://www.youtube.com/watch?v=SRM-Ia0XA30
For more information please contact The Excellence Center for Parkinson's Disease & Related Disorders, King Chulalongkorn Memorial Hospital, Geriatric Building or Sor Thor Building 7th floor, Tel. +66-2256-4000 ext. 70702-3, Fax +662-256-4000 ext. 70704, mobile phone +668-1107-9999, website: www.chulapd.org
Read the full article at https://www.chula.ac.th/en/news/218637/
About Chulalongkorn University
Chulalongkorn University has made the world's top 50 university list for employment outcomes, which reflects both the high employment rate and workability of Chula graduates. The university is also listed as the best in Thailand for the 15th Consecutive Year (since 2009), according to the newly released QS World University Rankings 2024, putting Chula at 211th in the world, up from 244th last year.
Social Media:
Facebook: https://www.facebook.com/ChulalongkornUniversity
Youtube: https://www.youtube.com/chulauniversity
Linkedin: https://www.linkedin.com/school/15101896/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Check PD: New Parkinson's Screening App with 90% Accuracy--Download Now!